epithelial and stromal expression of the secreted glycoprotein Dickkopf-related protein (Dkk)-3

epithelial and stromal expression of the secreted glycoprotein Dickkopf-related protein (Dkk)-3 is usually altered in age-related proliferative disorders of the human prostate. did not affect subcellular localization or levels of β-catenin but attenuated AKT phosphorylation in PrSCs. Consistently the PI3K/AKT inhibitor LY294002 mimicked the effects of knockdown. CONCLUSIONS?Dkk-3 promotes Belinostat (PXD101) fibroblast proliferation and myofibroblast differentiation and regulates expression of angiopoietin-1 in prostatic stroma potentially via enhancing PI3K/AKT signaling. Thus elevated Dkk-3 in the stroma of the diseased prostate presumably regulates stromal remodeling by enhancing proliferation and differentiation of stromal cells and contributing to the angiogenic switch observed in BPH and PCa. Therefore Dkk-3 Belinostat (PXD101) represents a potential therapeutic target for stromal remodeling in BPH and PCa. overexpression 3-19 However these effects appeared Belinostat (PXD101) to be caused by endoplasmatic reticulum stress (unfolded protein response) 18-19 which is generally induced by overexpression of highly-glycosylated secreted proteins such as Dkk-3 and thus might not reflect the biological role of endogenous Dkk-3. Indeed addition of exogenous recombinant Dkk-3 uniformly failed to reduce proliferation or induce apoptosis of malignant and nonmalignant cells 1 19 Moreover in the human pancreatic carcinoma cell collection PANC-1 overexpression of did not alter cellular proliferation while knockdown of resulted in significant reduction of cellular proliferation and concomitant induction of pancreatic epithelial cell differentiation markers indicating that Dkk-3 is required to maintain a highly dedifferentiated and proliferative state in these cells 21. BPH and PCa are both associated with changes in the stromal microenvironment (stromal remodeling) that actively promote disease development. In particular the Mouse monoclonal to SOD1 BPH and PCa-adjacent stroma are characterized by increased extracellular matrix deposition capillary density and differentiation of fibroblasts into myofibroblasts the mitogenic secretome of which promotes proliferation angiogenesis and tumorigenesis 22-25. TGFβ1 is considered to be a important inducer of pathogenic stromal reorganization and others and we have exhibited that TGFβ1 induces prostatic fibroblast-to-myofibroblast differentiation 26-30. Enhanced angiogenesis is also a key feature of the remodeled stroma. The angiogenic switch is a rate-limiting step in tumor progression 31 that is associated with a shift in the ratio of the vessel stabilizing angiopoietin-1 (overexpression reduced expression in a murine B16F10 melanoma model 34. Moreover Dkk-3 and were inversely regulated in human umbilical vein endothelial cells after knockdown of Axl 36 suggesting a role of Dkk-3 in tumor angiogenesis. This study aimed to investigate the functional significance of elevated stromal Dkk-3 in BPH and PCa by lentiviral-delivered overexpression and shRNA-mediated knockdown of in main prostatic stromal cells and analysis of the downstream effects on proliferation TGFβ1-induced fibroblast-to-myofibroblast differentiation and expression of angiogenic factors. MATERIALS AND METHODS Cell Culture and Fibroblast-to-Myofibroblast Differentiation Human main prostatic stromal cell (PrSC) and prostatic basal epithelial cell (PrEC) cultures were established as explained previously 1. PrSC were cultured in stromal cell growth medium (Quantum 333 PAA Laboratories) PrEC on collagen I-coated plates in prostate epithelial cell growth medium (PrEGM Clonetics). All experiments Belinostat (PXD101) were performed with main cells from at least three impartial donors. Fibroblast-to-myofibroblast differentiation was induced by 1?ng/ml TGFβ1 (R&D Systems) in RPMI 1640 (PAA Laboratories) containing 1% charcoal treated fetal calf serum (HyClone) and 1% penicillin/streptomycin (PAA Laboratories) as described 28. Control cells were treated with 1?ng/ml human basic fibroblast growth factor (bFGF; Sigma-Aldrich) as control to maintain the..